Overview

Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery

Status:
Withdrawn
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary aim of our prospective, randomized, double-blind interventional clinical trial is to determine the effectiveness of high dose atorvastatin therapy to reduce post operative cognitive dysfunction (POCD) in patients undergoing cardiac valve surgery. We hypothesize that therapy with high dose atorvastatin will significantly reduce the incidence and/or severity of POCD.
Phase:
N/A
Details
Lead Sponsor:
Duke University
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium